![Michael Tomsicek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tomsicek
Directeur/Membre du Conseil chez
MILESTONE PHARMACEUTICALS INC.
Fortune : 36 287 $ au 31/05/2026
Profil
M. Michael J. Tomsicek est un directeur non exécutif indépendant chez Milestone Pharmaceuticals, Inc. et un directeur financier et comptable principal chez CRISPR Therapeutics AG. Il est membre du conseil d'administration de Milestone Pharmaceuticals, Inc. et d'Optimer Pharmaceuticals LLC. Auparavant, M. Tomsicek a occupé les postes de directeur financier, de trésorier, d'agent comptable principal et de vice-président chez ABIOMED, Inc. et de trésorier chez Cubist Pharmaceuticals, Inc. et de directeur financier du Global Ultrasound Product Group chez General Electric Healthcare Technologies, Inc. et de directeur des finances et de la planification commerciale chez Motorola Automotive & Industrial Electronics Group, ainsi que celui de directeur financier chez The Lexington. Il a également été membre du conseil d'administration de Trius Therapeutics, Inc. Il a obtenu son diplôme de premier cycle à l'université du Wisconsin et un MBA à l'université du Wisconsin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 15 001 ( 0,01 % ) | 21 301 $ | 31/05/2026 | |
| 18/05/2026 | 9 366 ( 0,02 % ) | 14 986 $ | 31/05/2026 |
Postes actifs de Michael Tomsicek
| Sociétés | Poste | Début |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/04/2019 |
| ACRIVON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/10/2022 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Directeur/Membre du Conseil | 24/10/2013 |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Directeur/Membre du Conseil | 03/11/2022 |
Anciens postes connus de Michael Tomsicek
| Sociétés | Poste | Fin |
|---|---|---|
| CRISPR THERAPEUTICS AG | Directeur Financier/CFO | 14/10/2021 |
| ABIOMED, INC. | Directeur Financier/CFO | 24/08/2017 |
| CUBIST PHARMACEUTICALS INC | Directeur Financier/CFO | 01/01/2015 |
General Electric Healthcare Technologies, Inc.
 General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Corporate Officer/Principal | 01/09/2010 |
The Lexington
 The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Directeur Financier/CFO | - |
Formation de Michael Tomsicek
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Health Services |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Health Services |
Motorola Automotive & Industrial Electronics Group | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Health Technology |
